Philip Chase

Philip Chase is the current CEO at Adimab. Prior to their current position, they held various legal positions at large pharmaceutical companies. Philip began their career as an Associate at Shearman and Sterling in London, before moving to Skadden Arps in Boston. From there, they went on to work as Associate General Counsel for both Transkaryotic Therapies and RenaMed. Philip then served as General Counsel for Alnylam Pharmaceuticals from May 2007 to November of 2011. Philip Chase has extensive experience in the pharmaceutical industry, and has spent their career working in various legal capacities.

Philip Chase's educational career began at Devotion Elementary School. Philip then attended Newton North High School before going to Colby College for their BA. Finally, they attended Columbia Law School.

Some individuals on their team include Robert Pejchal - Senior Director, Antibody Engineering & Protein Analytics, Kirt Johnson - Senior Director, Product Engineering & Operations, and Kristin Rookey - Senior Director, Strategic Alliances.